High Tide is the clear leader in cannabis retail — the highest-revenue-generating cannabis company reporting in Canadian dollars, with annualized revenue now exceeding C$700 million.Unmatched Scale & Market Dominance
* Canna Cabana, its flagship brand, is Canada’s largest cannabis retail chain with over 220 locations and a leading \~12% market share across the five provinces where it operates — and the second-largest cannabis retail brand globally.
* Powered by the world’s largest cannabis loyalty program: Cabana Club (over 2.65 million members) and more than 178,000 paid ELITE members who drive high-margin, recurring revenue and industry-leading same-store sales growth (up 161% since the discount-club model launched, while peers declined).
* **Proven Execution & Profitability** High Tide consistently ranks among Canada’s Top Growing Companies (fifth consecutive year) and has delivered positive free cash flow, expanding margins, and accelerating growth through disciplined organic expansion and smart M&A.
**Global Expansion Underway**
In 2025, High Tide became the first North American operator to enter Germany’s medical cannabis market via a majority stake in Remexian Pharma — now holding \~14% market share in Europe’s largest federally regulated cannabis market. This diversifies revenue into high-growth international distribution while leveraging Canadian supply advantages.
Q3 could be the quarter that triggers a repricing: the preliminary guidance just announced points to new record highs for revenue, gross profit, and adjusted EBITDA, with projected Y/Y growth of at least 30%, 27% and 43%
[https://hightideinc.com/high-tide-announces-preliminary-q3-2026-guidance/](https://hightideinc.com/high-tide-announces-preliminary-q3-2026-guidance/)
https://preview.redd.it/un4qaog1r3lh1.png?width=1080&format=png&auto=webp&s=3aa47831da2935c21361b3a0df9fa9464f09197c
The Company Also Announces Record Quarterly Distribution of Over 10 Tonnes of Medical Cannabis Flower Through Remexian Pharma GmbH, Further Accelerating its German Market Position
https://preview.redd.it/se495gt3r3lh1.png?width=1080&format=png&auto=webp&s=5372abaf16f51e766688b78ec5f68ef63323ed1c
https://preview.redd.it/c59yunt4r3lh1.png?width=1024&format=png&auto=webp&s=ba168249c1667438a0d335b423334192f947d2c0
10 [$CAD](https://x.com/search?q=%24CAD&src=cashtag_click) doesn't strike me as an absurd target for a revaluation scenario. However, I wouldn't call it "fair value", simply because the chart shows a massive base. Requires the market to start pricing as a high-growth-profitable company rather than only a cannabis company
**Foundational years → progressive improvement in fundamentals → EBITDA/FCF+/Net income+ growth → market finally recognizing the new earning power → multiple expansion. And it is very different from simply saying “ High Tide is undervalued.”**
A base built over years, if broken while earnings are accelerating, can trigger a regime shift. That is why I wouldn't focus so much on "how much High Tide might rise from its current price," but rather on the EBITDA/FCF level at which the market might value HITI in 2027–28.
https://preview.redd.it/xljsar07r3lh1.png?width=1080&format=png&auto=webp&s=c962744380848e3628f317d84f8ae3279ff88e68
https://preview.redd.it/hlb928p7r3lh1.png?width=911&format=png&auto=webp&s=7e5f3c5ac805191c3327fb634001ac5d9f651d1a
**Company presentation :** [**https://hightideinc.com/presentation/**](https://hightideinc.com/presentation/)
* **Strengthened balance sheet**: The recent closing of C$40 million in senior secured credit facilities with the Bank of Montreal provides greater financial flexibility, a lower cost of capital, and the ability to fund growth without diluting shareholders.
* **Attractive valuation relative to results:** Despite consecutive record quarters and guidance that continues to beat expectations, the stock still trades at modest multiples compared with its growth profile and long-term potential. Many analysts see meaningful upside from current levels.
**Bottom line**
High Tide has repeatedly delivered in a tough industry: revenue growth, margin expansion, positive free cash flow, and steady market-share gains. With Canadian retail re-accelerating, Germany scaling rapidly, and a disciplined management team focused on execution, the disconnect between operational performance and market valuation still looks wide.The tide isn’t just rising — it’s building into a powerful wave. Investors positioned today may be well placed to benefit from one of the more compelling consolidation and internationalization stories in the cannabis sector.
As a long-term shareholder, I hope this post gave you some valuable insights.